
Nuceiva is commonly known as Jeuveau in the United States, an anti-aging injectable solution that can significantly reduce the appearance of lines in the forehead. Nuceiva is a neurotoxin derived from the Clostridium botulinum bacteria, a bacteria that can cause botulism in large doses.
However, in small doses, the bacteria are used to make botulinum toxin type A. The toxin prevents muscle contraction by blocking the release of acetylcholine in the neuromuscular synapses.
Nuceiva was approved by the FDA for human use in 2019, making it a safe and effective way to reduce lines between the eyebrows and enhance your appearance.
Evolus and Clarion Medical Technologies came together to produce the toxin and have since worked hard to ensure the solution is made using the latest proprietary technology and sold in planet-friendly packaging.
Nuceiva, also nicknamed Newtox, is the first neurotoxin to be approved for wrinkle treatments by Health Canada in over 20 years. This product was designed exclusively for cosmetic purposes, particularly to reduce the appearance of lines and wrinkles on the forehead and between the eyebrows.
Benefits |
|
---|---|
FAQs | What is Nuceiva Used For? |
Treatment Type | Injectables, Neurotoxins |
Treatment Problem or Condition | Facial Veins/Capillaries, Facial Volume Loss, Fine Lines, Wrinkles |
Brand | Jeuveau® |
How is Nuceiva Administered?
Nuceiva is administered as an injection into the muscles that contract and cause deep lines. Your healthcare provider will recommend an appropriate dose and frequency of treatment to ensure you receive the desired results while minimizing the risk of adverse side effects.
The professional administering your injections will ensure you are suitable for the treatment before receiving it. You shouldn’t get Nuceiva if:
- You are allergic to any of the ingredients in Nuceiva
- Have had a previous allergic reaction to other botulinum toxin products
- Have a skin infection at the planned injection site
The certification for Nuceiva is the same as Botox training, although it helps individuals planning on administering the drug to become more comfortable with it. Certification is required to administer Nuceiva or any other neurotoxin.
Each vial of JEUVEAU (prabotulinumtoxinA-xvfs) for injection contains 100 Units of botulinum toxin type A neurotoxin complex, human serum albumin (0.5 mg), and sodium chloride (0.9 mg) in a sterile, vacuum-dried form without a preservative.